Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun;43(6):1187-9.
doi: 10.1007/s00259-016-3354-0. Epub 2016 Mar 11.

(18)F-DOPA: the versatile radiopharmaceutical

David Taïeb  1 , Alessio Imperiale  2   3 , Karel Pacak  4
Affiliations

(18)F-DOPA: the versatile radiopharmaceutical

David Taïeb et al. Eur J Nucl Med Mol Imaging. 2016 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest None.

References

    1. Janssen I, Blanchet EM, Adams K, Chen CC, Millo C, Herscovitch P, et al. Superiority of [68Ga]-DOTATATE PET/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma. Clinical Cancer Res. 2015;21:3888–95. doi:10.1158/1078-0432.CCR-14-2751. - DOI - PMC - PubMed
    1. Bahri H, Laurence L, Edeline J, Leghzali H, Devillers A, Raoul JL, et al. High prognostic value of 18F-FDG PET for metastatic gastroenteropancreatic neuroendocrine tumors: a long-term evaluation. J Nucl Med. 2014;55:1786–90. doi:10.2967/jnumed.114.144386. - DOI - PubMed
    1. Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther. 2009;121:29–40. doi:10.1016/j.pharmthera.2008.09.005. - DOI - PubMed
    1. Montravers F, Kerrou K, Nataf V, Huchet V, Lotz JP, Ruszniewski P, et al. Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors. J Clin Endocrinol Metab. 2009;94:1295–301. doi:10.1210/jc.2008-1349. - DOI - PubMed
    1. Montravers F, Grahek D, Kerrou K, Ruszniewski P, de Beco V, Aide N, et al. Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors? J Nucl Med. 2006;47:1455–62. - PubMed

MeSH terms

LinkOut - more resources